reference/30246217

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/30246217

Outgoing Links

Predicate	Object
contentType	Comparative Study\|Journal Article\|Multicenter Study
endingPage	813
issn	0009-9236 1532-6535
issueIdentifier	6
pageRange	809-813
publicationName	Clinical pharmacology and therapeutics
startingPage	809
bibliographicCitation	Takahashi N, Wakita H, Miura M, Scott SA, Nishii K, Masuko M, Sakai M, Maeda Y, Ishige K, Kashimura M, Fujikawa K, Fukazawa M, Katayama T, Monma F, Narita M, Urase F, Furukawa T, Miyazaki Y, Katayama N, Sawada K. Correlation Between Imatinib Pharmacokinetics and Clinical Response in Japanese Patients With Chronic‐Phase Chronic Myeloid Leukemia. Clinical Pharmacology & Therapeutics. 2010 Oct 27;88(6):809–13. doi: 10.1038/clpt.2010.186.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6465977b313d9951c3761fb14e3d576e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b0d37c3797ce01b2f99167f056aca2bf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3df5f2f40daafd1d7ca69e0f6ee8f65c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f3bf02f34368009eecbd1c940a2a8b25 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_afbe2c714a148609549eed40e0860914 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f87afb3931febffb9deebe87424faec9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ef3aa0b09a168a756b9c29d8cb24e0c3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_09fec5997b01e6bd503eba7f1d220c0a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7b9b53a28d785e74e2ce7b01a0842e91 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b017a66cf5226672264e649da433479a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a53d2d2363e1bdac6c54aa4fda8241c9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8b21eb8da1c0017e038fbc93adeb885e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_faea673d1dade2e94bee81486f556113 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5f277b31f805ea1b476520ef7e558739 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_08d16f5d417cf1232c718c1effdcca83 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_64a83aa1c8d04b085a5d2a2d3f8ad107 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e66a8016dce92b05ccd67891e76bc8c4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ece74606db60488ed165d089a74e8980 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f5bd2fe66af769775172d5bd7a59f08f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_517549cd98b9b3246058024816b12384
date	2010-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/20980997 https://doi.org/10.1038/clpt.2010.186
isPartOf	https://portal.issn.org/resource/ISSN/1532-6535 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3058 https://portal.issn.org/resource/ISSN/0009-9236
language	English
source	https://www.crossref.org/ https://scigraph.springernature.com/ https://pubmed.ncbi.nlm.nih.gov/
title	Correlation Between Imatinib Pharmacokinetics and Clinical Response in Japanese Patients With Chronic-Phase Chronic Myeloid Leukemia
discusses	http://id.nlm.nih.gov/mesh/M0391958 http://id.nlm.nih.gov/mesh/M0002327 http://id.nlm.nih.gov/mesh/M0016884 http://id.nlm.nih.gov/mesh/M0018260
hasSubjectTerm	http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102 http://purl.org/au-research/vocabulary/anzsrc-for/2008/11
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9727 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9729 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123596 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5291

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128433595

Total number of triples: 51.